Our research involves the application of nutrition and nutrigenetics to the nutraceutical prevention and post-onset management of type 2 diabetes in humans, with a view to the reduction of polypharmacy.
Supports the bioproducts, bioscience, bioagriculture and chemical manufacturing sectors through research and innovation, testing and prototyping, and training.